Recent progress in the battle between oncolytic viruses and tumours
Top Cited Papers
- 18 November 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 5 (12) , 965-976
- https://doi.org/10.1038/nrc1750
Abstract
In the past 5 years, the field of oncolytic virus research has matured significantly and is moving past the stage of being a laboratory novelty into a new era of preclinical and clinical trials. What have recent anticancer trials of oncolytic viruses taught us about this exciting new line of therapeutics?Keywords
This publication has 115 references indexed in Scilit:
- A critical function for type I interferons in cancer immunoeditingNature Immunology, 2005
- Rescue and propagation of fully retargeted oncolytic measles virusesNature Biotechnology, 2005
- VSV Disrupts the Rae1/mrnp41 mRNA Nuclear Export PathwayMolecular Cell, 2005
- Expressed Gene Clusters Associated with Cellular Sensitivity and Resistance Towards Anti-viral and Anti-proliferative Actions of InterferonJournal of Molecular Biology, 2004
- Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivoBiochemical and Biophysical Research Communications, 2004
- Antibody-targeted cell fusionNature Biotechnology, 2004
- Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on a New Hemagglutinin Structural ModelJournal of Virology, 2004
- Regulation of eIF2α Phosphorylation by Different Functions That Act during Discrete Phases in the Herpes Simplex Virus Type 1 Life CycleJournal of Virology, 2003
- Measles Virus Infects and Suppresses Proliferation of T Lymphocytes from Transgenic Mice Bearing Human Signaling Lymphocytic Activation MoleculeJournal of Virology, 2003
- PKR-Dependent Mechanisms of Gene Expression from a Subgenomic Hepatitis C Virus CloneJournal of Virology, 2002